ArticleAnalytical chemistry2026
Preanalytical Workflow Establishment for Reproducible Clinical Blood-Based Infrared Molecular Fingerprinting.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Standardized preanalytical sample handling is a cornerstone of reliable molecular analytics, particularly where subtle multimolecular differences can drive biological interpretation. In different clinical studies, blood-based samples are often processed using varying workflows, and the influence of individual technical parameters remains poorly quantified. In particular, preanalytical differences can limit study comparability and complicate the robust evaluation of the approach for different applications and specific medical questions. Here, we systematically investigate the effects of major preanalytical variables on infrared molecular fingerprinting (IMF) of blood serum and plasma, performed via Fourier transform infrared (FTIR) spectroscopy. We examine the impacts of venous blood draw tube types, tube fill volumes, delay times prior to centrifugation, centrifugation conditions, freezing and thawing procedures, and delay times between final sample preparation and infrared spectroscopy. We found that the type of blood collection tube, the fill volume of the tube, a delay of more than 4 h before centrifugation, more than two freeze-thaw cycles, and delays prior to measurement can result in systematic changes in infrared fingerprints that are detectable through multivariate analysis and machine learning. Importantly, for most conditions, the magnitude of parameter-related spectral variation remains smaller than the intrinsic biological variability across individuals, supporting the feasibility of IMF for realistic clinical settings. The presented results provide actionable guidance and a basis for harmonizing preanalytical workflows, reducing preanalytical confounding in IMF-based biofluid analysis, and improving cross-study comparability, with relevance that may generalize to other molecular profiling technologies, clinical studies, and biobanking.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.